{
  "id": 12909071,
  "title": "Income Tax Dept. appeals against tax relief favouring Dr Lal PathLabs; stock falls 2.4%",
  "url": "https://urgent.news/2026/10/08/income-tax-dept-appeals-against-tax-relief-favouring-dr-lal-pathlabs",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-08T16:58:43.000Z",
  "source": {
    "name": "Hindu BusinessLine",
    "slug": "hindu-businessline",
    "url": "https://www.thehindubusinessline.com/markets/stock-markets/income-tax-dept-appeals-against-tax-relief-favouring-dr-lal-pathlabs-stock-falls-24/article71559748.ece"
  },
  "original_language": "en",
  "account": "On October 7, 2026, the Income Tax Department filed an appeal before the Income Tax Appellate Tribunal (ITAT) in New Delhi, challenging a recent ruling in favor of Dr Lal PathLabs Limited. The company had been granted tax relief on disallowances of Employee Stock Option Plan (ESOP) expenses worth ₹32.66 crore for the assessment year 2022-23, as per Section 250 of the Income Tax Act, 1961. This latest development in the ongoing tax dispute stemmed from an assessment order received in April 2024, followed by an appellate order in July 2026. Despite the appeal, the company does not anticipate the ITAT decision to materially impact its operations. Dr Lal PathLabs shares closed at ₹1,898.90 on the National Stock Exchange (NSE) on Thursday, marking a 2.38 percent decrease from the previous close of ₹1,945.10. The broader market also experienced a decline. The stock trades at a trailing price-to-earnings (P/E) ratio of 59.76 and holds a market capitalization of around ₹31,873 crore. So far this year, the stock has delivered a return of 25.70 percent, significantly surpassing the Nifty 500.",
  "summary": "The tax dispute follows an assessment order in April 2024 and an appellate ruling in July 2026 favouring the company",
  "key_points": [
    "Income Tax Dept. appeals against Dr Lal PathLabs tax relief",
    "Shares fall 2.4% to ₹1,898.90 on NSE",
    "Company sees no material impact on operations"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}